VeroScience   Report issue

For profit Phase 4
Founded: Tiverton RI United States (2002)
Status: No NME R&D (2002)

Organization Overview

First Clinical Trial
2004
NCT00377676
First Marketed Drug
2009
bromocriptine (parlodel)
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

VEROSCIENCE

Active Ingredients

Marketed Drugs (1)

bromocriptine (parlodel) (2009)

Drugs in Phase 4 Trials (1)

bromocriptine (parlodel) (4 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2 (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 1